Home > News > FDA delegation attends TUC Congress 2026

FDA delegation attends TUC Congress 2026

FDA General Secretary Dave Penman seconds the vote of thanks to this year’s TUC President Steve Gillan, General Secretary of the Prison Officers’ Association

This week, the FDA attended the 2026 TUC Congress in Brighton. FDA delegates spoke to and moved motions on a range of topics, including the review of the civil service, supporting effective management, accountability and safe contracting in the NHS, and the importance of an evidence-led approach to regulation.

Delegates included FDA President Leila Kelly, General Secretary Dave Penman, Vice President Beatriz Brown, Executive Committee members Cleo Lunt and Sandra Wilson, and Managers in Partnership (FDA’s joint venture with Unison, representing healthcare managers) Executive Committee member Sajidah Ahmad.

Review of the civil service

Penman moved one of the FDA’s two motions, Motion 54 on review of the civil service, where he outlined the importance of a review that not only looks at efficiency and delivery, but also covers how to safeguard the core values of the service. The General Secretary told congress: “It it is a permanent civil service that ensures, regardless of political turmoil, that the lights stay on.”

Delegates passed the motion.


Effective NHS management

The FDA also moved Motion 52 on supporting effective management in the NHS, which called on Congress to back the call to recognise the vital role of NHS managers and invest properly in the leadership and management needed in the health service. Delegate Sajidah Ahmad stressed: “behind every hospital ward, community service and major NHS programme, are people making sure those services function.”

This motion was also passed by delegates.


Regulation

FDA President Leila Kelly moved the FDA’s amendment on Motion 31a from Prospect, on defending regulators and opposing deregulation, with the FDA expanding the motion to include the call for an an evidence-led approach to regulation and standards across the economy. Kelly stated: “it’s not that we cannot afford regulation, it’s that we cannot afford not to have it.”

The amendment was accepted by delegates and the motion passed.


Accountability and safe contracting in the NHS

FDA Executive Committee member Cleo Lunt moved the FDA’s amendment to Motion 46 from Society of Radiographers, on accountability and safe contracting in the NHS, which expanded the motion to ensure that NHS organisations have the management capacity and capability to support effective governance.

Lunt told delegates that, “managers also need to be supported in order to do that job properly. We can’t just move the onus from the employer to the individual manager. Everybody needs to be fully supported and have the tools they need to do this difficult work in the best way possible.”

The motion, including the FDA’s amendment, was passed by delegates.

Latest news